Envision

Two Labs, an Envision Pharma Group company acquires Riparian

The partnership expands Two Labs’ suite of services and broadens its integration competency to include government price reporting London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP (GHO), the European specialist investor in global healthcare, acknowledges the announcement from its portfolio company, Envision Pharma Group, regarding the acquisition of Riparian by Two Labs.… read more

Envision Pharma Group acquires Two Labs to advance its position as a global strategic partner to pharma

Acquisition follows increased investment in Envision from GHO Capital and its partners Two Labs brings market-leading commercialisation, strategic consulting, market access, and market intelligence solutions that span the full product life cycle Move builds on Envision’s established leadership position as the preferred tech-enabled scientific communications company for medical affairs, while deepening its presence in the… read more

GHO Capital and management acquire Ardian majority stake in Envision Pharma Group to accelerate continued growth

London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP (GHO), the European specialist investor in healthcare, together with the existing Envision management team and employees, have increased their investment in Envision Pharma Group (“Envision” or the “Company”), a leading technology-enabled scientific communications company. The transaction sees GHO lead a consortium of its investors headed… read more

Subscribe to our email alerts

Email updates